Dual Inhibition of EGFR with Afatinib and Cetuximab in Kinase Inhibitor-Resistant EGFR-Mutant Lung Cancer with and without T790M Mutations

Y.Y. Janjigian, E.F. Smit, H.J.M. Groen, L. Horn, S. Gettinger, D.R. Camidge, G.J. Riely, B.S. Wang, Y. Fu, V.K. Chand, V.A. Miller, W. Pao

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)1036-1045
JournalCancer discovery
Issue number9
Publication statusPublished - 2014

Cite this